- FOR ADULTS WITH TYPE 2 DIABETES
Mounjaro® (Tirzepatide)
KwikPens & Injectable Presentations for Global Pharmaceutical Supply
Reliable sourcing, pharmaceutical expertise and international supply support for qualified healthcare buyers, distributors, hospitals, and licensed medical importers.
Pen & Injectable Presentations
Multi-strength · Cold-chain packaged · Batch-documented for export
Export Compliance
GDP & Cold Chain
Documentation
COA & Certificate of Origin
Buyer Eligibility
Licensed B2B Entities Only
- INN · Tirzepatide
- Rx Only
- Our Products
Mounjaro is proven to lower A1C in adults with type 2 diabetes*
Mounjaro is an injectable prescription medicine that is used along with diet and exercise to improve blood sugar (glucose) in adults and children 10 years of age and older with type 2 diabetes mellitus.
It is not known if Mounjaro is safe and effective for use in children under 10 years of age.
Mounjaro® at a Glance
Core pharmacological specifications for authorized medical importers and procurement officers.
Tirzepatide
First-in-class dual GIP/GLP-1 receptor agonist
Once Weekly
Fixed day dosing schedule, independent of meals
Mounjaro®
Manufactured by Eli Lilly and Company
Prescription Medicine (POM)
Restricted to licensed healthcare channels
Subcutaneous Injection
Administered into abdomen, thigh, or upper arm
Type 2 Diabetes & Weight Management*
Indications vary by regional health authority
Two Pathways. One Active Ingredient.
Tirzepatide is a single molecule engineered to activate both GIP and GLP-1 hormone receptors.
- Dual Receptor Agonist
Synergistic GIP & GLP-1 Receptor Activation
By mimicking both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1), tirzepatide enhances first- and second-phase insulin secretion, decreases glucagon concentrations, and slows gastric emptying.
Incretin hormone pathway
+
Incretin hormone pathway
- Clinical Efficacy Pillars
1. Blood Glucose Management
Improves glycemic control through glucose-dependent insulin secretion and suppression of inappropriately elevated glucagon.
2. Weight Management
Supports significant reductions in body weight through appetite regulation and reduced caloric intake.
3. Once-Weekly Administration
Optimized pharmacokinetic profile allowing stable once-weekly subcutaneous dosing for improved compliance.
- OUR PRODUCTS
All Mounjaro Strengths, In Stock for Export
Presentation availability is subject to current stock and manufacturer allocation. Submit a requirement to receive confirmed availability for your market.
*Indications and availability vary by country. Always verify local regulatory requirements before marketing or importing.
- Safety Summary
Clinical safety overview
Mounjaro® (Tirzepatide) is a prescription medicine that must be handled and dispensed in accordance with local regulatory guidelines.
- Prescription Only: Restricted strictly to licensed medical procurement and qualified healthcare dispensing.
- Gastrointestinal Considerations: Common adverse reactions may include nausea, vomiting, diarrhea, decreased appetite, constipation, and abdominal discomfort.
- Medical Supervision: Treatment requires ongoing supervision by a qualified healthcare professional.
- Contraindications: Refer to the full prescribing information regarding a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Official Disclaimer: “Always refer to the locally approved product information and consult a qualified healthcare professional prior to administration or clinical procurement.”
Brand:
Mounjaro®
Active Molecule:
Tirzepatide
Manufacturer:
Eli Lilly & Company
Role of Divy Tradelink:
Sourcing & export partner
- Original Manufacturer
Mounjaro® by Eli Lilly
Mounjaro® is developed and manufactured by Eli Lilly and Company. Divy Tradelink operates independently as a specialized international pharmaceutical sourcing, export, and B2B supply partner.
How to Use Mounjaro®
Standard 5-step subcutaneous KwikPen administration workflow.
01
Choose Your Weekly Day
Take Mounjaro® once a week, preferably on the same day each week. Your healthcare professional will advise you on the appropriate dose and schedule.
02
Prepare Your Pen
Before use, check the pen and medication according to the instructions provided with the product. Follow the preparation steps specific to your Mounjaro® pen presentation.
03
Select Your Injection Site
Mounjaro® is injected under the skin of the abdomen, thigh, or upper arm. Follow your healthcare professional’s guidance on injection sites and technique.
04
Administer & Dispose Safely
Administer the injection according to the official pen instructions. After use, dispose of the pen or injection device appropriately according to local medical waste requirements.
- Faq
Frequently Asked Questions
From sourcing to delivery, we ensure reliability at every step. Our operations follow strict quality and regulatory standards.
What is Mounjaro®?
Mounjaro® is a prescription injectable medicine containing Tirzepatide, indicated for the treatment of type 2 diabetes mellitus and adult weight management under qualified medical supervision.
What is Tirzepatide?
Is Mounjaro prescription-only?
How often is it administered?
What presentations are available?
Mounjaro® presentations, strengths and pack formats vary by market and current supply position. Share your destination and requirement so the export desk can confirm applicable options.
Can Divy Tradelink supply internationally?
Yes. Divy Tradelink specializes in international pharmaceutical export, regulatory document support, and temperature-controlled cold-chain logistics to licensed distributors, hospitals, and clinics worldwide.